C-TRI Co.
1998
FOUNDED
PUBLIC
STATUS
101-200
EMPLOYEES
047920
STOCK SYMBOL
$4.67
SHARE PRICE
(As of Friday Closing)
Description
Chem Tech Research Inc is a research oriented pharmaceutical company. It is engaged in developing Peptide drugs, Antiviral drugs and Ionic liquids. Its products include Bivalirudin, Goserlin, leuprolide and Oseltamivir derivatives.
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
KRX
Primary Office
- 778-1 Ilpae Dong
- Namyangiu, 472-930
- South Korea
+82 000-000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore C-TRI Co.’s full profile, request a free trial.
C-TRI Co. Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $2.35 - $6.46 | $64.7M | $4.46 | -$0.09 | 439K | 13.8M |
C-TRI Co. Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 52,769 | 51,045 | 80,584 | 48,103 |
| Revenue | 28,431 | 18,688 | 13,720 | 17,463 |
| EBITDA | 1,456 | (3,738) | (2,586) | 1,287 |
| Net Income | (1,260) | (6,423) | (4,803) | 496 |
| Total Assets | 30,307 | 32,570 | 37,288 | 34,124 |
| Total Debt | 5,209 | 6,880 | 13,993 | 12,535 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
C-TRI Co. Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore C-TRI Co.‘s full profile, request access.
Request full access to PitchBookC-TRI Co. Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore C-TRI Co.‘s full profile, request access.
Request full access to PitchBook